Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-Exposed B cells

Journal of Immunology

Volumn 192, Issue 8, 2014, Pages 3626-3636

  Caro Maldonado, Alfredo ^a,b   Wang, Ruoning ^c   Nichols, Amanda G ^a,b   Kuraoka, Masayuki ^a   Milasta, Sandra ^d   Sun, Lillian D ^a,b   Gavin, Amanda L ^e   Abel, E Dale ^f   Kelsoe, Garnett ^a   Green, Douglas R ^d   Rathmell, Jeffrey C ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e BURNET INSTITUTE   (Australia)

^f UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; ANTIBODY FORMATION; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; CLONAL ANERGY; DICHLOROACETIC ACID; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLYCOLYSIS; HOMEOSTASIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; MITOCHONDRIA; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-MYC; T-LYMPHOCYTES;

EID: 84898606445     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302062     Document Type: Article

References (46)

1. Rathmell, J. C. 2012. Metabolism and autophagy in the immune system: immunometabolism comes of age. Immunol. Rev. 249: 5-13.
2. Frauwirth, K. A., J. L. Riley, M. H. Harris, R. V. Parry, J. C. Rathmell, D. R. Plas, R. L. Elstrom, C. H. June, and C. B. Thompson. 2002. The CD28 signaling pathway regulates glucose metabolism. Immunity 16: 769-777.
3. Jacobs, S. R., C. E. Herman, N. J. Maciver, J. A. Wofford, H. L. Wieman, J. J. Hammen, and J. C. Rathmell. 2008. Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J. Immunol. 180: 4476-4486.
4. Wang, R., and D. R. Green. 2012. Metabolic reprogramming and metabolic dependency in T cells. Immunol. Rev. 249: 14-26.
5. Wang, R. N., C. P. Dillon, L. Z. Shi, S. Milasta, R. Carter, D. Finkelstein, L. L. McCormick, P. Fitzgerald, H. B. Chi, J. Munger, and D. R. Green. 2011. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35: 871-882.
6. Vander Heiden, M. G., L. C. Cantley, and C. B. Thompson. 2009. Understanding theWarburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033.
7. Vats, D., L. Mukundan, J. I. Odegaard, L. Zhang, K. L. Smith, C. R. Morel, R. A. Wagner, D. R. Greaves, P. J. Murray, and A. Chawla. 2006. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. [Published erratum appears in 2006 Cell Metab. 4: 255.] Cell Metab. 4: 13-24.
8. Krawczyk, C. M., T. Holowka, J. Sun, J. Blagih, E. Amiel, R. J. DeBerardinis, J. R. Cross, E. Jung, C. B. Thompson, R. G. Jones, and E. J. Pearce. 2010. Tolllike receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115: 4742-4749.
9. Doughty, C. A., B. F. Bleiman, D. J. Wagner, F. J. Dufort, J. M. Mataraza, M. F. Roberts, and T. C. Chiles. 2006. Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth. Blood 107: 4458-4465.
10. Dufort, F. J., B. F. Bleiman, M. R. Gumina, D. Blair, D. J.Wagner, M. F. Roberts, Y. Abu-Amer, and T. C. Chiles. 2007. Cutting edge: IL-4-mediated protection of primary B lymphocytes from apoptosis via Stat6-dependent regulation of glycolytic metabolism. J. Immunol. 179: 4953-4957.
11. MacIver, N. J., R. D. Michalek, and J. C. Rathmell. 2013. Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 31: 259-283.
12. Cham, C. M., G. Driessens, J. P. O'Keefe, and T. F. Gajewski. 2008. Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells. Eur. J. Immunol. 38: 2438-2450.
13. Cham, C. M., and T. F. Gajewski. 2005. Glucose availability regulates IFNgamma production and p70S6 kinase activation in CD8+ effector T cells. J. Immunol. 174: 4670-4677.
14. Blair, D., F. J. Dufort, and T. C. Chiles. 2012. Protein kinase Cb is critical for the metabolic switch to glycolysis following B-cell antigen receptor engagement. Biochem. J. 448: 165-169.
15. Chang, C. H., J. D. Curtis, L. B. Maggi, Jr., B. Faubert, A. V. Villarino, D. O'Sullivan, S. C. Huang, G. J. van der Windt, J. Blagih, J. Qiu, et al. 2013. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153: 1239-1251.
16. Michalek, R. D., V. A. Gerriets, S. R. Jacobs, A. N. Macintyre, N. J. MacIver, E. F. Mason, S. A. Sullivan, A. G. Nichols, and J. C. Rathmell. 2011. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 186: 3299-3303.
17. Zhu, J., H. Yamane, and W. E. Paul. 2010. Differentiation of effector CD4 T cell populations. Annu. Rev. Immunol. 28: 445-489.
18. Dang, E. V., J. Barbi, H. Y. Yang, D. Jinasena, H. Yu, Y. Zheng, Z. Bordman, J. Fu, Y. Kim, H. R. Yen, et al. 2011. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 146: 772-784.
19. Shi, L. Z., R. Wang, G. Huang, P. Vogel, G. Neale, D. R. Green, and H. Chi. 2011. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208: 1367-1376.
20. Johnson, A. R., J. J. Milner, and L. Makowski. 2012. The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol. Rev. 249: 218-238.
21. Pearce, E. L., M. C. Walsh, P. J. Cejas, G. M. Harms, H. Shen, L. S. Wang, R. G. Jones, and Y. Choi. 2009. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460: 103-107.
22. van der Windt, G. J., B. Everts, C. H. Chang, J. D. Curtis, T. C. Freitas, E. Amiel, E. J. Pearce, and E. L. Pearce. 2012. Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 36: 68-78.
23. Zheng, Y., G. M. Delgoffe, C. F. Meyer, W. Chan, and J. D. Powell. 2009. Anergic T cells are metabolically anergic. J. Immunol. 183: 6095-6101.
24. Pillai, S., H. Mattoo, and A. Cariappa. 2011. B cells and autoimmunity. Curr. Opin. Immunol. 23: 721-731.
25. Boneparth, A., and A. Davidson. 2012. B-cell activating factor targeted therapy and lupus. Arthritis Res. Ther. 14(Suppl. 4): S2.
26. Zhang, J., V. Roschke, K. P. Baker, Z. Wang, G. S. Alarcón, B. J. Fessler, H. Bastian, R. P. Kimberly, and T. Zhou. 2001. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J. Immunol. 166: 6-10.
27. Mackay, F., S. A. Woodcock, P. Lawton, C. Ambrose, M. Baetscher, P. Schneider, J. Tschopp, and J. L. Browning. 1999. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190: 1697-1710.
28. Ota, M., B. H. Duong, A. Torkamani, C. M. Doyle, A. L. Gavin, T. Ota, and D. Nemazee. 2010. Regulation of the B cell receptor repertoire and selfreactivity by BAFF. J. Immunol. 185: 4128-4136.
29. Patke, A., I. Mecklenbräuker, H. Erdjument-Bromage, P. Tempst, and A. Tarakhovsky. 2006. BAFF controls B cell metabolic fitness through a PKC beta-and Akt-dependent mechanism. J. Exp. Med. 203: 2551-2562.
30. Woodland, R. T., C. J. Fox, M. R. Schmidt, P. S. Hammerman, J. T. Opferman, S. J. Korsmeyer, D. M. Hilbert, and C. B. Thompson. 2008. Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival. Blood 111: 750-760.
31. Gavin, A. L., B. Duong, P. Skog, D. Aït-Azzouzene, D. R. Greaves, M. L. Scott, and D. Nemazee. 2005. deltaBAFF, a splice isoform of BAFF, opposes full-length BAFF activity in vivo in transgenic mouse models. J. Immunol. 175: 319-328.
32. de Alboran, I. M., R. C. O'Hagan, F. Gärtner, B. Malynn, L. Davidson, R. Rickert, K. Rajewsky, R. A. DePinho, and F. W. Alt. 2001. Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity 14: 45-55.
33. de Luca, C., T. J. Kowalski, Y. Zhang, J. K. Elmquist, C. Lee, M. W. Kilimann, T. Ludwig, S. M. Liu, and S. C. Chua, Jr. 2005. Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes. J. Clin. Invest. 115: 3484-3493.
34. Young, C. D., A. S. Lewis, M. C. Rudolph, M. D. Ruehle, M. R. Jackman, U. J. Yun, O. Ilkun, R. Pereira, E. D. Abel, and S. M. Anderson. 2011. Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo. PLoS One 6: e23205.
35. Wieman, H. L., J. A. Wofford, and J. C. Rathmell. 2007. Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking. Mol. Biol. Cell 18: 1437-1446.
36. Kuraoka, M., D. Liao, K. Yang, S. D. Allgood, M. C. Levesque, G. Kelsoe, and Y. Ueda. 2009. Activation-induced cytidine deaminase expression and activity in the absence of germinal centers: insights into hyper-IgM syndrome. J. Immunol. 183: 3237-3248.
37. van der Windt, G. J., and E. L. Pearce. 2012. Metabolic switching and fuel choice during T-cell differentiation and memory development. Immunol. Rev. 249: 27-42.
38. DeBerardinis, R. J., J. J. Lum, G. Hatzivassiliou, and C. B. Thompson. 2008. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7: 11-20.
39. Goodnow, C. C., J. Sprent, B. Fazekas de St. Groth, and C. G. Vinuesa. 2005. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435: 590-597.
40. Yarkoni, Y., A. Getahun, and J. C. Cambier. 2010. Molecular underpinning of B-cell anergy. Immunol. Rev. 237: 249-263.
41. Goodnow, C. C. 2001. Pathways for self-tolerance and the treatment of autoimmune diseases. Lancet 357: 2115-2121.
42. Browne, C. D., C. J. Del Nagro, M. H. Cato, H. S. Dengler, and R. C. Rickert. 2009. Suppression of phosphatidylinositol 3,4,5-trisphosphate production is a key determinant of B cell anergy. Immunity 31: 749-760.
43. Ramírez-Peinado, S., F. Alcázar-Limones, L. Lagares-Tena, N. El Mjiyad, A. Caro-Maldonado, O. M. Tirado, and C. Munöz-Pinedo. 2011. 2-Deoxyglucose induces Noxa-dependent apoptosis in alveolar rhabdomyosarcoma. Cancer Res. 71: 6796-6806.
44. Kaplon, J., L. Zheng, K. Meissl, B. Chaneton, V. A. Selivanov, G. Mackay, S. H. van der Burg, E. M. Verdegaal, M. Cascante, T. Shlomi, et al. 2013. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature 498: 109-112.
45. McBrayer, S. K., J. C. Cheng, S. Singhal, N. L. Krett, S. T. Rosen, and M. Shanmugam. 2012. Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy. Blood 119: 4686-4697.
46. Perl, A., G. Nagy, P. Gergely, F. Puskas, Y. Qian, and K. Banki. 2004. Apoptosis and mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus. Methods Mol. Med. 102: 87-114.